Femasys Inc. (FEMY) Competitors & Peers
The 5 largest companies in the same industry as Femasys Inc., by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| ISRG | Peer | $393.33 | P/E 45.1RSI 61Cap 140.9 B |
| MDLN | Peer | $31.64 | P/E 39.5RSI 36Cap 27.8 B |
| BDX | Peer | $180.94 | P/E 31.4RSI 51Cap 49.3 B |
| ALC | Peer | $65.04 | P/E 49.6RSI 31Cap 31.4 B |
| RMD | Peer | $224.99 | P/E 21.6RSI 50Cap 32.5 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Confirmed relationships (cited)
Sourced from a public filing or disclosure — each links to its origin.
- BAYRYSupplier
Own 10-K customer-concentration disclosure: BayerYakuhinLtd = 10% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- IQVPartner
IQVIA provides contract clinical research and trial management services (CRO).
Model-inferred, unverified — treat as a lead, not evidence - AMZNSupplier
Utilizes AWS cloud infrastructure to host genomic sequencing data and clinical trial databases.
Model-inferred, unverified — treat as a lead, not evidence - PFECompetitor
Competes in development and commercialization of therapeutics for similar indications.
Model-inferred, unverified — treat as a lead, not evidence